Ping An Biomedical Co., Ltd. (PASW)

Ping An Biomedical Income Statement

Financials in millions CNY. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023
Revenue	34.15	87.62	82.56
Revenue Growth (YoY)	-61.03%	6.13%	-
Cost of Revenue	33.2	82.21	78.32
Gross Profit	0.95	5.42	4.24
Selling, General & Admin	6.31	5.3	3.6
Other Operating Expenses	9.34	0.12	0.03
Total Operating Expenses	15.65	5.42	3.63
Operating Income	-14.7	-0	0.61
Interest Income	0.33	0	0.16
Interest Expense	-0.31	-0.71	-1.74
Other Non-Operating Income (Expense)	-0	0.02	1.01
Total Non-Operating Income (Expense)	0.02	-0.68	-0.57
Pretax Income	-14.68	-0.68	0.04
Provision for Income Taxes	-1.86	0.6	1.04
Net Income	-12.83	-1.28	-0.99
Net Income to Common	-12.83	-1.28	-0.99
Shares Outstanding (Basic)	18	18	18
Shares Outstanding (Diluted)	18	18	18
Shares Change (YoY)	2.66%	-	-
EPS (Basic)	-0.69	-0.06	-0.07
EPS (Diluted)	-0.69	-0.06	-0.07
Free Cash Flow	-6.43	14.63	-6.08
Free Cash Flow Per Share	-0.35	0.81	-0.34
Gross Margin	2.78%	6.18%	5.14%
Operating Margin	-43.05%	-0.00%	0.74%
Profit Margin	-37.57%	-1.47%	-1.20%
FCF Margin	-18.82%	16.70%	-7.37%
EBITDA	-14.7	0.01	0.65
EBITDA Margin	-43.04%	0.01%	0.78%
EBIT	-14.7	-0	0.61
EBIT Margin	-43.05%	-0.00%	0.74%
Effective Tax Rate	12.64%	-88.10%	2484.34%

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.